Colorectal cancer incidence on the General Practice Research Database

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 7, 2012, Pages 775-783

  Charlton, Rachel ^a   Snowball, Julia ^a   Bloomfield, Katherine ^a,b   de Vries, Corinne ^a  

^a University of Bath   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Case validation; Colorectal cancer; Colorectal neoplasms; GPRD; Incidence

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; COLORECTAL CANCER; ELECTRONIC MEDICAL RECORD; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SEX DIFFERENCE; TREND STUDY; UNITED KINGDOM;

EID: 84863548892     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3236     Document Type: Article

References (14)

1. Garcia-Rodriguez LA, Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and non-aspirin non-steroidal anti-inflammatory drugs. Epidemiology 2001; 12: 88-93.
2. Meier CR, Schmitz S, Jick H. Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer. Pharmacotherapy 2002; 22(3): 303-309.
3. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004; 127(4): 1044-1050.
4. van Staa TP, Card T, Logan RF, et al. 5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut 2005; 54: 1573-1578.
5. Yang YX, Hennessy S, Propert K, et al. Chronic proton pump inhibitor therapy and the risk of colorectal cancer. Gastroenterology 2007; 133(3): 748-754.
6. Yang YX, Hennessy S, Propert K, et al. Chronic statin therapy and the risk of colorectal cancer. Pharmacoepidemiol Drug Saf 2008; 17(9): 869-876.
7. Cancer Research UK. Bowel (colorectal) cancer-UK incidence statistics. Available from: 2010. [Accessed on 12 January 2010].
8. MHRA. The General Practice Research Database. Available from: 2010. [Accessed on 9 January 2010].
9. Office for National Statistics. Cancer statistics registrations: registrations of cancer diagnosed in 2007, England. Available from: 2010. [Accessed 11 January 2010].
10. Sharp L. National Cancer Registry. Cork: Ireland, 2010.
11. Lewis JD, Bilker W, Weinstein RB, et al. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Phamacoepidemiol Drug Saf 2005; 14: 443-451.
12. Haynes K, Forde KA, Schinnar R, et al. Cancer incidence in The Health Improvement Network. Pharmacoepidemiol Drug Saf 2009; 18(8): 730-736.
13. Tate AR, Martin AGR, Murry-Thomas T, et al. Determining the date of diagnosis-is it a simple matter? The impact of different approaches to dating diagnosis on estimates of delayed care for ovarian cancer in UK primary care. BMC Med Res Methodol 2009; 9(42).
14. Tate AR, Martin AGR, Ali A, et al. Using free text information to explore how and when GPs code a diagnosis of ovarian cancer: an observational study using primary care records of patients with ovarian cancer. BMJ Open 2011; 1(1):e000025.